Bone Marrow Failure Syndromes Terminated Phase 2 Trials for Clofarabine (DB00631)

Also known as: Bone Marrow Failure Syndrome

IndicationStatusPhase
DBCOND0035172 (Bone Marrow Failure Syndromes)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01596699Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell TransplantationTreatment